Article

ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma

2023-07-26

Abstract excerpt

<h4>ABSTRACT</h4> Immunotherapy is increasingly viewed as treatment of choice for lung cancer, however, clinical responses to immune checkpoint blockade remain highly unpredictable and are largely transient. A deeper mechanistic understanding of the dynamics of tumour:immune interactions is needed to drive rational development of improved treatment strategies. Progress is hampered by a paucity of autochthonous mo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: faebdafc-754f-512b-bb8f-e0f74455c573
DOI: 10.1101/2023.07.24.550274

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinomaDOI 10.1101/2023.07.24.550274Read

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy combinationsSemantic proximity Read

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.Semantic proximity Read

Characterisation of a novel genetically engineered mouse model of non-small cell lung cancer with a dynamic immune responseSemantic proximity Read

Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung AdenocarcinomaSemantic proximity Read

Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models.Semantic proximity Read

Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaSemantic proximity Read

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinomaSemantic proximity Read

Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.Semantic proximity Read

Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancerSemantic proximity Read

Genetic determinants of <i>EGFR</i> -Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>Semantic proximity Read

BRAF <sup>V600E</sup> -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor SignalingSemantic proximity Read

Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.Semantic proximity Read